Thoth Science Inc. will present its pipeline at 'BIO CEO & Investor Conference' in New York

Summary

Thoth Science Inc. and 3 other South Korean biotechnology companies will join the ‘BIO CEO & Investor Conference’ of New York in February 2020, to present their pipelines. Thoth Science Inc. is a company that focuses on diabetes treatment and NASH (Nonalcoholic Steatohepatitis) by utilizing stem cells and the cell encapsulation tool, TheraCyte.

Link to the Full Article (in Korean)